Abstract
Hemodiafiltration is a form of renal replacement therapy which employs convection and diffusion to enhance the clearance of larger uremic solutes which are not adequately removed by conventional low-flux hemodialysis. Most modern dialysis machines are able to deliver hemodiafiltration. The main limiting factor that prevents its widespread implementation is the requirement for dialysis units to be capable of producing large quantities of ultrapure dialysis fluid. The benefits of hemodiafiltration include better hemodynamic stability and enhanced clearance of middle molecules such as ß2-microglobulin, especially in patients without residual kidney function. There may be a survival advantage with hemodiafiltration particularly when delivering high convective volumes although this requires confirmation in future clinical trials. Hemodiafiltration is a safe and effective mode of renal replacement therapy which offers some advantages over conventional hemodialysis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Babb AL, Popovich RP, Christopher TG, Scribner BH. The genesis of the square meter-hour hypothesis. Trans Am Soc Artif Intern Organs. 1971;17:81–91.
Henderson LW, Besarab A, Michaels A, Bluemle LW. Blood purification by ultrafiltration and fluid replacement (diafiltration). Hemodial Int. 2004;8(1):10–8.
Leypoldt JK. Solute fluxes in different treatment modalities. Nephrol Dial Transpl. 2000;15(Suppl 1):3–9.
Leber HW, Wizemann V, Goubeaud G, Rawer P, Schütterle G. Simultaneous hemofiltration/hemodialysis: an effective alternative to hemofiltration and conventional hemodialysis in the treatment of uremic patients. Clin Nephrol. 1978;9(3):115–21.
Wizemann V, Rawer P, Schütterle G. Ultrashort hemodiafiltration: long term efficiency and hemodynamic tolerance. Proc Eur Dial Transplant Assoc. 1983;19:175–81.
Wizemann V, Kramer W. Short-term dialysis—long-term complications. Ten years experience with short-duration renal replacement therapy. Blood Purif. 1987;5(4):193–201.
Tattersall J. Clearance of beta-2-microglobulin and middle molecules in hemodiafiltration. Contrib Nephrol. 2007;158:201–9.
Henderson LW. The birth of hemodiafiltration. Contrib Nephrol. 2007;158:1–8.
Roy T, Ahrenholz P, Falkenhagen D, Klinkmann H. Volumetrically controlled ultrafiltration. Current experiences and future prospects. Int J Artif Organs. 1982;5(3):131–5.
Ronco C, Fabris A, Feriani M, Chiaramonte S, Brendolan A, Bragantini L, et al. Technical and clinical evaluation of a new system for ultrafiltration control during hemodialysis. ASAIO Trans. 34(3):613–6.
Henderson LW, Beans E. Successful production of sterile pyrogen-free electrolyte solution by ultrafiltration. Kidney Int. 1978;14(5):522–5.
Henderson LW, Sanfelippo ML, Beans E. “On line” preparation of sterile pyrogen-free electrolyte solution. Trans Am Soc Artif Intern Organs. 1978;24:465–7.
Ronco C, Ghezzi PM, Brendolan A, Crepaldi C, La Greca G. The hemodialysis system : basic mechanisms of water and solute transport in extracorporeal renal replacement therapies. Nephrol Dial Transpl. 1998;13(Suppl 6):3–9.
Tattersall JE, Ward RA. Online hemodiafiltration: definition, dose quantification and safety revisited. Nephrol Dial Transpl. 2013;28(3):542–50.
van der Weerd NC, Penne EL, van den Dorpel MA, Grooteman MPC, Nube MJ, Bots ML, et al. Hemodiafiltration: promise for the future? Nephrol Dial Transpl. 2008;23(2):438–43.
Ronco C, Orlandini G, Brendolan A, Lupi A, La Greca G. Enhancement of convective transport by internal filtration in a modified experimental hemodialyzer: technical note. Kidney Int. 1998;54(3):979–85.
Krieter DH, Falkenhain S, Chalabi L, Collins G, Lemke H-D, Canaud B. Clinical cross-over comparison of mid-dilution hemodiafiltration using a novel dialyzer concept and post-dilution hemodiafiltration. Kidney Int. 2005;67(1):349–56.
Bowry S, Canaud B. Achieving high convective volumes in on-line hemodiafiltration. Blood Purif. 2013;35(Suppl 1):23–8.
Canaud B, Chenine L, Renaud S, Leray H. Optimal therapeutic conditions for online hemodiafiltration. Contrib Nephrol. 2011;168:28–38.
Ledebo I. On-line preparation of solutions for dialysis: practical aspects versus safety and regulations. J Am Soc Nephrol. 2002;13(Suppl 1):S78–83.
Grooteman MPC, van den Dorpel MA, Bots ML, Penne EL, van der Weerd NC, Mazairac AHA, et al. Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. J Am Soc Nephrol. 2012;23(6):1087–96.
Ok E, Asci G, Toz H, Ok ES, Kircelli F, Yilmaz M, et al. Mortality and cardiovascular events in online hemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study. Nephrol Dial Transpl. 2013;28(1):192–202.
Maduell F, Moreso F, Pons M, Ramos R, Mora-Macià J, Carreras J, et al. High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J Am Soc Nephrol. 2013;24(3):487–97.
Wang AY, Ninomiya T, Al-Kahwa A, Perkovic V, Gallagher MP, Hawley C, et al. Effect of hemodiafiltration or hemofiltration compared with hemodialysis on mortality and cardiovascular disease in chronic kidney failure: a systematic review and meta-analysis of randomized trials. Am J Kidney Dis. 2014;63(6):968–78.
Nistor I, Palmer SC, Craig JC, Saglimbene V, Vecchio M, Covic A, et al. Convective versus diffusive dialysis therapies for chronic kidney failure: an updated systematic review of randomized controlled trials. Am J Kidney Dis. 2014;63(6):954–67.
Susantitaphong P, Jaber BL. Understanding discordant meta-analyses of convective dialytic therapies for chronic kidney failure. Am J Kidney Dis. 2014;63(6):888–91.
Fry AC, Singh DK, Chandna SM, Farrington K. Relative importance of residual renal function and convection in determining beta-2-microglobulin levels in high-flux hemodialysis and on-line hemodiafiltration. Blood Purif. 2007;25(3):295–302.
Penne EL, van der Weerd NC, Blankestijn PJ, van den Dorpel MA, Grooteman MPC, Nubé MJ, et al. Role of residual kidney function and convective volume on change in beta2-microglobulin levels in hemodiafiltration patients. Clin J Am Soc Nephrol. 2010;5(1):80–6.
Farrington K, Davenport A. The ESHOL study: hemodiafiltration improves survival-but how? Kidney Int. 2013;83(6):979–81.
Cheung AK, Rocco MV, Yan G, Leypoldt JK, Levin NW, Greene T, et al. Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol. 2006;17(2):546–55.
Okuno S, Ishimura E, Kohno K, Fujino-Katoh Y, Maeno Y, Yamakawa T, et al. Serum beta2-microglobulin level is a significant predictor of mortality in maintenance hemodialysis patients. Nephrol Dial Transplant. 2009;24(2):571–7.
Wizemann V, Lotz C, Techert F, Uthoff S. On-line hemodiafiltration versus low-flux hemodialysis. A prospective randomized study. Nephrol Dial Transpl. 2000;15(Suppl 1):43–8.
Schiffl H. Prospective randomized cross-over long-term comparison of online hemodiafiltration and ultrapure high-flux hemodialysis. Eur J Med Res. 2007;12(1):26–33.
Locatelli F, Mastrangelo F, Redaelli B, Ronco C, Marcelli D, La Greca G, et al. Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. The Italian cooperative dialysis study group. Kidney Int. 1996;50(4):1293–302.
Ward RA, Schmidt B, Hullin J, Hillebrand GF, Samtleben W. A comparison of on-line hemodiafiltration and high-flux hemodialysis: a prospective clinical study. J Am Soc Nephrol. 2000;11(12):2344–50.
Lornoy W, Becaus I, Billiouw JM, Sierens L, Van Malderen P, D’Haenens P. On-line hemodiafiltration. Remarkable removal of beta2-microglobulin. Long-term clinical observations. Nephrol Dial Transplant. 2000;15(Suppl 1):49–54.
Termorshuizen F, Dekker FW, van Manen JG, Korevaar JC, Boeschoten EW, Krediet RT. Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. J Am Soc Nephrol. 2004;15(4):1061–70.
Vilar E, Wellsted D, Chandna SM, Greenwood RN, Farrington K. Residual renal function improves outcome in incremental hemodialysis despite reduced dialysis dose. Nephrol Dial Transplant. 2009;24(8):2502–10.
Babb AL, Ahmad S, Bergström J, Scribner BH. The middle molecule hypothesis in perspective. Am J Kidney Dis. 1981;1(1):46–50.
Bargman J, Golper T. The importance of residual renal function for patients on dialysis. Nephrol Dial Transpl. 2005;20:671–3.
Hsu P-Y, Lin C-L, Yu C-C, Chien C-C, Hsiau T-G, Sun T-H, et al. Ultrapure dialysate improves iron utilization and erythropoietin response in chronic hemodialysis patients-a prospective cross-over study. J Nephrol. 17(5):693–700.
Sitter T, Bergner A, Schiffl H. Dialysate related cytokine induction and response to recombinant human erythropoietin in hemodialysis patients. Nephrol Dial Transpl. 2000;15(8):1207–11.
Vilar E, Fry AC, Wellsted D, Tattersall JE, Greenwood RN, Farrington K. Long-term outcomes in online hemodiafiltration and high-flux hemodialysis: a comparative analysis. Clin J Am Soc Nephrol. 2009;4(12):1944–53.
Panichi V, Rizza GM, Paoletti S, Bigazzi R, Aloisi M, Barsotti G, et al. Chronic inflammation and mortality in hemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study. Nephrol Dial Transpl. 2008;23(7):2337–43.
Den Hoedt CH, Bots ML, Grooteman MPC, van der Weerd NC, Mazairac AHA, Penne EL, et al. Online hemodiafiltration reduces systemic inflammation compared to low-flux hemodialysis. Kidney Int. 2014;86(2):423–32.
Locatelli F, Altieri P, Andrulli S, Bolasco P, Sau G, Pedrini LA, et al. Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD. J Am Soc Nephrol. 2010;21(10):1798–807.
Donauer J, Schweiger C, Rumberger B, Krumme B, Böhler J. Reduction of hypotensive side effects during online-hemodiafiltration and low temperature hemodialysis. Nephrol Dial Transpl. 2003;18(8):1616–22.
Jansen MAM, Hart AAM, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int. 2002;62(3):1046–53.
Penne EL, Visser L, van den Dorpel MA, van der Weerd NC, Mazairac AHA, van Jaarsveld BC, et al. Microbiological quality and quality control of purified water and ultrapure dialysis fluids for online hemodiafiltration in routine clinical practice. Kidney Int. 2009;76(6):665–72.
McBrien KA, Manns BJ. Hemodiafiltration: not effective or cost-effective compared with hemodialysis. Nephrol Dial Transplant. 2013;28(7):1630–3; discussion 1633.
Oates T, Cross J, Davenport A. Cost comparison of online hemodiafiltration with high-flux hemodialysis. J Nephrol. 25(2):192–7.
Maduell F, del Pozo C, Garcia H, Sanchez L, Hdez-Jaras J, Albero MD, et al. Change from conventional hemodiafiltration to on-line hemodiafiltration. Nephrol Dial Transpl. 1999;14(5):1202–7.
Eiselt J, Racek J, Opatrny K. The effect of hemodialysis and acetate-free biofiltration on anemia. Int J Artif Organs. 2000;23(3):173–80.
Lin CL, Huang CC, Chang CT, Wu MS, Hung CC, Chien CC, et al. Clinical improvement by increased frequency of on-line hemodialfiltration. Ren Fail. 2001;23(2):193–206.
Vinhas J, Vaz Á, Barreto C, Assunção J. Survival advantage of patients on hemodiafiltration is independent of dialysis dose and patient characteristics: data from a single centre. Port J Nephrol Hypert. 2007;21(4):287–92.
Spalding EM, Pandya P, Farrington K. Effect of high haematocrit on the efficiency of high-flux dialysis therapies. Nephron Clin Pract. 2008;110(2):c86–92.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Wong, J., Sridharan, S., Greenwood, R., Farrington, K. (2016). Hemodiafiltration. In: Magee, C., Tucker, J., Singh, A. (eds) Core Concepts in Dialysis and Continuous Therapies. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-7657-4_23
Download citation
DOI: https://doi.org/10.1007/978-1-4899-7657-4_23
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-7655-0
Online ISBN: 978-1-4899-7657-4
eBook Packages: MedicineMedicine (R0)